Arvee Laboratories (India) Ltd. (NSE:ARVEE)

India flag India · Delayed Price · Currency is INR
139.18
-6.10 (-4.20%)
Feb 14, 2025, 9:15 AM IST
-2.67%
Market Cap 1.53B
Revenue (ttm) 381.81M
Net Income (ttm) 21.94M
Shares Out 11.02M
EPS (ttm) 1.99
PE Ratio 69.99
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 228
Average Volume 530
Open 144.80
Previous Close 145.28
Day's Range 138.01 - 145.00
52-Week Range 117.05 - 315.00
Beta 0.57
RSI 31.18
Earnings Date Feb 7, 2025

About NSE:ARVEE

Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India and internationally. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, ... [Read more]

Sector Materials
Founded 2012
Employees 65
Stock Exchange National Stock Exchange of India
Ticker Symbol ARVEE
Full Company Profile

Financial Performance

In 2023, NSE:ARVEE's revenue was 303.45 million, a decrease of -50.54% compared to the previous year's 613.47 million. Earnings were 10.52 million, a decrease of -74.46%.

Financial Statements

News

There is no news available yet.